MedPath

A comparison of intranasal dexmedetomidine versus placebo in attenuation of hemodynamic responses to laryngoscopy and intubatio

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2022/07/044460
Lead Sponsor
Kidwai memorial institute of oncology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients aged between 18 to 65 years belonging to ASA status 1 ad 2 with BMI between 18 -25 kgm2 undergoing surgery under general anesthesia

Exclusion Criteria

Patient refusal. Patient with known nasal pathology. History of allergy to study drug or other anesthetic agents.patient with history ischemic heart disease, cerebrovascular accident, or cardiovascular disease. Patient with second or third degree heart blocks. Patients on long term sedatives or anxiolytics. Patients on Anti hypertensive like clonidine, beta blockers, alpha methyl dopa, alpha adrenergic agonists.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath